Skip to main content
Clinical Trials/NCT05464303
NCT05464303UnknownNot Applicable

Establishment and Validation of a Standardized Definition for Biliary Atresia Associated Cholangitis After Hepatic Portoenterostomy

Nanjing Children's Hospital1 site in 1 country500 target enrollmentStarted: July 15, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
500
Locations
1
Primary Endpoint
Diagnostic cholangitis score

Study Overview

Brief Summary

Cholangitis is the most common postoperative complication of biliary atresia, with a reported incidence of 40-90%, which seriously affects the surgical effect, survival rate and the quality of life and prognosis of patients. Without of direct evidence, the diagnosis of cholangitis sometimes is difficult to make, thus most of them are diagnosed based on the symptoms of children. According to literature reports, different centers and regions have different diagnostic criteria for postoperative cholangitis after hepatic portoenterostomy, which has a great influence on the accuracy of the incidence rate and appropriate treatment of cholangitis, and also brings differences in the analysis of the causes and prognostic factors of cholangitis.

Based on the above reasons, we used the Delphi method,in which worldwidely 48 experts participated in, to establish the diagnostic scoring system for postoperative cholangitis after biliary atresia.

Now we aimed to verify the specificity and sensitivity of the new scoring system through clinical cases, in order to unify and standardize the diagnostic criteria and provide help for the diagnosis and treatment of cholangitis after biliary atresia.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ① Admission time: 2019.01.01-2021.12.31;
  • ② The first diagnosis after discharge was cholangitis

Exclusion Criteria

  • ① Cholangitis after non-Kasai procedure;
  • Postoperative cholangitis of biliary atresia not operated in the unit; ③ Patient has been treated in other hospitals during this episode; ④ The treatment period for cholangitis is not completed or the patient is discharged automatically.

Arms & Interventions

Postoperative cholangitis

Patients who had conducted kasai procedure and suffered from postoperative cholangitis after surgery

Intervention: Intravenous Antibodies (Drug)

Outcomes

Primary Outcomes

Diagnostic cholangitis score

Time Frame: Two years

The values of the two groups' scores were calculated separately

Secondary Outcomes

  • Score estimates for treatment of cholangitis(Two years)

Investigators

Sponsor
Nanjing Children's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Weibing Tang

Dr

Nanjing Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials